Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Viruses ; 13(6)2021 06 14.
Article in English | MEDLINE | ID: covidwho-1270128

ABSTRACT

Humoral immunity has emerged as a vital immune component against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Nevertheless, a subset of recovered Coronavirus Disease-2019 (COVID-19) paucisymptomatic/asymptomatic individuals do not generate an antibody response, constituting a paradox. We assumed that immunodiagnostic assays may operate under a competitive format within the context of antigenemia, potentially explaining this phenomenon. We present a case where persistent antigenemia/viremia was documented for at least 73 days post-symptom onset using 'in-house' methodology, and as it progressively declined, seroconversion took place late, around day 55, supporting our hypothesis. Thus, prolonged SARS-CoV-2 antigenemia/viremia could mask humoral responses, rendering, in certain cases, the phenomenon of 'non-responders' a misnomer.


Subject(s)
Antibodies, Viral/blood , Antigens, Viral/blood , Antigens, Viral/immunology , COVID-19 Serological Testing/standards , COVID-19/diagnosis , SARS-CoV-2/immunology , Antibodies, Viral/metabolism , Antigens, Viral/metabolism , Binding Sites, Antibody , COVID-19/blood , COVID-19/immunology , COVID-19/virology , COVID-19 Serological Testing/statistics & numerical data , Humans , Immunity, Humoral/immunology , Immunoglobulin G/blood , Male , Sensitivity and Specificity , Seroconversion , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL